Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups

Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation
CFDA 93.943 Active Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$2.2M FY2026
$2.4M
FY24
$2.2M
FY25
$2.2M
FY26*
* estimated

Program Objective

To support promising epidemiologic and implementation of science research in racial/ethnic minority communities disproportionately affected by HIV, while strengthening the capacity for conducting such research among investigators working in these communities.

Eligibility

Eligible Applicants

  • Other

Reference posted NOFOs available on Grants.gov

Beneficiaries

  • Unrestricted by Entity Type

State and local health agencies; private research organizations, public and private nonprofit organizations, for profit organizations; minority groups, including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and persons physically afflicted with AIDS/HIV infection.

How to Apply

Award Procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public.

Decision Timeline

  • Approval: From 120 to 180 days
  • Renewal interval: From 120 to 180 days
Program details & compliance

Description

The EHE plan encompasses the following four key strategies: (i) diagnose all individuals with HIV as early as possible; (ii) treat people with HIV rapidly and effectively to reach sustained viral suppression; (iii) prevent new HIV transmissions by using proven interventions, including PrEP and syringe services programs (SSPs); (iv) respond quickly to potential HIV outbreaks to get needed prevention and treatment services to people who need them.

Mission Categories

Primary: Prevention and Control (includes Suicide Prevention)

Use of Funds

Allowed Uses

Assistance is provided to support cooperative agreements that examine important epidemiologic research issues concerning AIDS and HIV infection. The research should contribute to the health services knowledge base from which empirically based information can be derived by policy makers, both immediately and over the coming decades. Grants include funds for direct costs (such as personnel, travel, equipment, or supplies) necessary to carry out an approved project as well as funds for the reimbursement of applicable indirect costs. Unallowable costs, as well as those for which prior written approval is required, are indicated in the HHS Grants Policy Statement.

Required Documentation

Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.

Reporting & Compliance

Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Arin Williams
4046398432
1600 Clifton Road, MS H-24-6, Atlanta, GA 30333
Nicolas Rankin
4044980226
1600 Clifton Road, MS E-07, Atlanta, GA 30329
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-09. Spec v2.0. Last synced: 2026-05-30 02:30:22.